LISATA THERAPEUTICS, INC. — Director's Dealing 2011

Apr 6, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-04-04

Reporting Person: Smith Robin L (Director, Chairman of Board and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-04-04	Stock Options (right to buy)	$1.74	A	1500000	Acquired	2021-04-03	Common Stock, par value $0.001 per share (1500000)	Direct

Footnotes

F1: On April 4, 2011 (the "Grant Date"), the effective date of an amendment and extension of her employment agreement with
NeoStem, Inc. (the "Company"), Dr. Smith was granted an option to purchase 1,500,000 shares of common stock under the
Company's 2009 Equity Compensation Plan (the "2009 Plan"). This option vests as to 500,000 shares on each of the Grant Date,
December 31, 2011 and December 31, 2012. The option is subject to all the terms and conditions of the 2009 Plan.